The importance of the Thr17 residue of phospholamban as a phosphorylation site under physiological and pathological conditions

The sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA2a) is under the control of an SR protein named phospholamban (PLN). Dephosphorylated PLN inhibits SERCA2a, whereas phosphorylation of PLN at either the Ser16 site by PKA or the Thr17 site by CaMKII reverses this inhibition, thus increasing SERCA2a a...

Full description

Bibliographic Details
Main Authors: A. Mattiazzi, C. Mundiña-Weilenmann, L. Vittone, M. Said, E.G. Kranias
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2006-05-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000500001
_version_ 1811204060047474688
author A. Mattiazzi
C. Mundiña-Weilenmann
L. Vittone
M. Said
E.G. Kranias
author_facet A. Mattiazzi
C. Mundiña-Weilenmann
L. Vittone
M. Said
E.G. Kranias
author_sort A. Mattiazzi
collection DOAJ
description The sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA2a) is under the control of an SR protein named phospholamban (PLN). Dephosphorylated PLN inhibits SERCA2a, whereas phosphorylation of PLN at either the Ser16 site by PKA or the Thr17 site by CaMKII reverses this inhibition, thus increasing SERCA2a activity and the rate of Ca2+ uptake by the SR. This leads to an increase in the velocity of relaxation, SR Ca2+ load and myocardial contractility. In the intact heart, ß-adrenoceptor stimulation results in phosphorylation of PLN at both Ser16 and Thr17 residues. Phosphorylation of the Thr17 residue requires both stimulation of the CaMKII signaling pathways and inhibition of PP1, the major phosphatase that dephosphorylates PLN. These two prerequisites appear to be fulfilled by ß-adrenoceptor stimulation, which as a result of PKA activation, triggers the activation of CaMKII by increasing intracellular Ca2+, and inhibits PP1. Several pathological situations such as ischemia-reperfusion injury or hypercapnic acidosis provide the required conditions for the phosphorylation of the Thr17 residue of PLN, independently of the increase in PKA activity, i.e., increased intracellular Ca2+ and acidosis-induced phosphatase inhibition. Our results indicated that PLN was phosphorylated at Thr17 at the onset of reflow and immediately after hypercapnia was established, and that this phosphorylation contributes to the mechanical recovery after both the ischemic and acidic insults. Studies on transgenic mice with Thr17 mutated to Ala (PLN-T17A) are consistent with these results. Thus, phosphorylation of the Thr17 residue of PLN probably participates in a protective mechanism that favors Ca2+ handling and limits intracellular Ca2+ overload in pathological situations.
first_indexed 2024-04-12T03:05:06Z
format Article
id doaj.art-92d064fbec204916a5a0b80ac807e9c6
institution Directory Open Access Journal
issn 0100-879X
1414-431X
language English
last_indexed 2024-04-12T03:05:06Z
publishDate 2006-05-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-92d064fbec204916a5a0b80ac807e9c62022-12-22T03:50:31ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2006-05-0139556357210.1590/S0100-879X2006000500001The importance of the Thr17 residue of phospholamban as a phosphorylation site under physiological and pathological conditionsA. MattiazziC. Mundiña-WeilenmannL. VittoneM. SaidE.G. KraniasThe sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA2a) is under the control of an SR protein named phospholamban (PLN). Dephosphorylated PLN inhibits SERCA2a, whereas phosphorylation of PLN at either the Ser16 site by PKA or the Thr17 site by CaMKII reverses this inhibition, thus increasing SERCA2a activity and the rate of Ca2+ uptake by the SR. This leads to an increase in the velocity of relaxation, SR Ca2+ load and myocardial contractility. In the intact heart, ß-adrenoceptor stimulation results in phosphorylation of PLN at both Ser16 and Thr17 residues. Phosphorylation of the Thr17 residue requires both stimulation of the CaMKII signaling pathways and inhibition of PP1, the major phosphatase that dephosphorylates PLN. These two prerequisites appear to be fulfilled by ß-adrenoceptor stimulation, which as a result of PKA activation, triggers the activation of CaMKII by increasing intracellular Ca2+, and inhibits PP1. Several pathological situations such as ischemia-reperfusion injury or hypercapnic acidosis provide the required conditions for the phosphorylation of the Thr17 residue of PLN, independently of the increase in PKA activity, i.e., increased intracellular Ca2+ and acidosis-induced phosphatase inhibition. Our results indicated that PLN was phosphorylated at Thr17 at the onset of reflow and immediately after hypercapnia was established, and that this phosphorylation contributes to the mechanical recovery after both the ischemic and acidic insults. Studies on transgenic mice with Thr17 mutated to Ala (PLN-T17A) are consistent with these results. Thus, phosphorylation of the Thr17 residue of PLN probably participates in a protective mechanism that favors Ca2+ handling and limits intracellular Ca2+ overload in pathological situations.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000500001PhospholambanThr17 site phosphorylationß-adrenergic stimulationAcidosisIschemia
spellingShingle A. Mattiazzi
C. Mundiña-Weilenmann
L. Vittone
M. Said
E.G. Kranias
The importance of the Thr17 residue of phospholamban as a phosphorylation site under physiological and pathological conditions
Brazilian Journal of Medical and Biological Research
Phospholamban
Thr17 site phosphorylation
ß-adrenergic stimulation
Acidosis
Ischemia
title The importance of the Thr17 residue of phospholamban as a phosphorylation site under physiological and pathological conditions
title_full The importance of the Thr17 residue of phospholamban as a phosphorylation site under physiological and pathological conditions
title_fullStr The importance of the Thr17 residue of phospholamban as a phosphorylation site under physiological and pathological conditions
title_full_unstemmed The importance of the Thr17 residue of phospholamban as a phosphorylation site under physiological and pathological conditions
title_short The importance of the Thr17 residue of phospholamban as a phosphorylation site under physiological and pathological conditions
title_sort importance of the thr17 residue of phospholamban as a phosphorylation site under physiological and pathological conditions
topic Phospholamban
Thr17 site phosphorylation
ß-adrenergic stimulation
Acidosis
Ischemia
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000500001
work_keys_str_mv AT amattiazzi theimportanceofthethr17residueofphospholambanasaphosphorylationsiteunderphysiologicalandpathologicalconditions
AT cmundinaweilenmann theimportanceofthethr17residueofphospholambanasaphosphorylationsiteunderphysiologicalandpathologicalconditions
AT lvittone theimportanceofthethr17residueofphospholambanasaphosphorylationsiteunderphysiologicalandpathologicalconditions
AT msaid theimportanceofthethr17residueofphospholambanasaphosphorylationsiteunderphysiologicalandpathologicalconditions
AT egkranias theimportanceofthethr17residueofphospholambanasaphosphorylationsiteunderphysiologicalandpathologicalconditions
AT amattiazzi importanceofthethr17residueofphospholambanasaphosphorylationsiteunderphysiologicalandpathologicalconditions
AT cmundinaweilenmann importanceofthethr17residueofphospholambanasaphosphorylationsiteunderphysiologicalandpathologicalconditions
AT lvittone importanceofthethr17residueofphospholambanasaphosphorylationsiteunderphysiologicalandpathologicalconditions
AT msaid importanceofthethr17residueofphospholambanasaphosphorylationsiteunderphysiologicalandpathologicalconditions
AT egkranias importanceofthethr17residueofphospholambanasaphosphorylationsiteunderphysiologicalandpathologicalconditions